Pancreatic Cancer Research

ResearcherOU Health Stephenson Cancer CenterActive in the last 2 years

Ralf Janknecht

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1741-1562; OpenAlex author ID A5046942450; NIH RePORTER profile ID 6180918. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
1
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant

Papers 1

  1. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase… Co-author DOI 10.1186/1476-4598-13-103↗

Grants 1

  1. Role of JMJD4 in Pancreatic Cancer R03CA292973↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sripathi M. Sureban · 1 shared paper, 2014 · strength 0.04
  2. Nathaniel Weygant · 1 shared paper, 2014 · strength 0.04
  3. Courtney W. Houchen · 1 shared paper, 2014 · strength 0.04
  4. Dongfeng Qu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.